Annual Cash & Cash Equivalents
$14.80 M
-$8.64 M-36.86%
December 31, 2022
Summary
- As of February 10, 2025, APGNW annual cash & cash equivalents is $14.80 million, with the most recent change of -$8.64 million (-36.86%) on December 31, 2022.
- During the last 3 years, APGNW annual cash & cash equivalents has fallen by -$10.48 million (-41.46%).
Performance
APGNW Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.37 M
-$3.36 M-26.40%
June 30, 2023
Summary
- As of February 10, 2025, APGNW quarterly cash and cash equivalents is $9.37 million, with the most recent change of -$3.36 million (-26.40%) on June 30, 2023.
- Over the past year, APGNW quarterly cash and cash equivalents has dropped by -$67.60 million (-87.83%).
Performance
APGNW Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
APGNW Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.9% | -87.8% |
| 3 y3 years | -41.5% | +100.0% |
| 5 y5 years | -41.5% | +100.0% |
APGNW Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.9% | at low | -87.8% | -97.7% |
| 5 y | 5-year | -41.5% | at low | -87.8% | -100.0% |
| alltime | all time | -41.5% | at low | -87.8% | -100.0% |
Apexigen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $9.37 M(-26.4%) |
| Mar 2023 | - | $12.73 M(-14.0%) |
| Dec 2022 | $14.80 M | $14.80 M(+16.5%) |
| Sep 2022 | - | $12.71 M(-83.5%) |
| Jun 2022 | - | $76.97 M(+338.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $17.55 M(+7972.8%) |
| Dec 2021 | $23.44 M(-7.3%) | $217.41 K(-20.8%) |
| Sep 2021 | - | $274.49 K(-22.0%) |
| Jun 2021 | - | $352.13 K(>+9900.0%) |
| Dec 2020 | $25.28 M | - |
| Jun 2020 | - | $0.00 |
FAQ
- What is Apexigen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Apexigen?
- What is Apexigen annual cash & cash equivalents year-on-year change?
- What is Apexigen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Apexigen?
- What is Apexigen quarterly cash and cash equivalents year-on-year change?
What is Apexigen annual cash & cash equivalents?
The current annual cash & cash equivalents of APGNW is $14.80 M
What is the all time high annual cash & cash equivalents for Apexigen?
Apexigen all-time high annual cash & cash equivalents is $25.28 M
What is Apexigen annual cash & cash equivalents year-on-year change?
Over the past year, APGNW annual cash & cash equivalents has changed by -$8.64 M (-36.86%)
What is Apexigen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APGNW is $9.37 M
What is the all time high quarterly cash and cash equivalents for Apexigen?
Apexigen all-time high quarterly cash and cash equivalents is $76.97 M
What is Apexigen quarterly cash and cash equivalents year-on-year change?
Over the past year, APGNW quarterly cash and cash equivalents has changed by -$67.60 M (-87.83%)